Subtype-specific mechanisms can be unveiled through WES and WGS studies focusing on tumor subgroups (Table 4): WES and WGS studies on GH-PTs have identified dysregulation of multiple signaling pathways as potential tumorigenic mechanisms, although they need to be characterized further using functional studies. The gene discussed is GH1; the disease is neoplasm.